Abstract

BK polyomavirus (BKV) nephropathy is a major concern in renal transplantation. Its main consequence is graft loss, which occurs in more than 50% of the cases. De novo renal cell carcinoma in renal allograft is a very rare event. Most of these tumors are papillary or clear cell carcinomas. We report herein the first case of collecting duct carcinoma of the renal allograft in a kidney-pancreas allograft adult recipient. Collecting duct carcinoma occurs long after the cure of a BKV nephropathy. At this time, BKV viremia and viruria were negative as well as the immunostaining for SV40 in the non-tumor kidney. The viral oncoprotein Tag persists only in the tumor cells. To preserve pancreas graft function, we maintained immunosuppression levels. After a 9-months follow-up, the evolution was free from clinical and radiological progression. The oncogenic role of BKV remains controversial in human cancers. However, strong experimental data have shown an association between BKV infection and urologic neoplasms. Further works might precise the exact role of polyomaviruses in renal carcinogenesis. In the meantime, clinical vigilance for early diagnostic of these tumors is mandatory after BKV nephropathy.

Highlights

  • BK polyomavirus (BKV) infection represents a major concern in renal transplantation

  • BK polyomavirus (BKV) nephropathy is a major concern in renal transplantation

  • We report the first case of collecting duct carcinoma of the renal allograft in a kidney-pancreas allograft adult recipient

Read more

Summary

INTRODUCTION

BK polyomavirus (BKV) infection represents a major concern in renal transplantation. The prevalence of BKV nephropathy in kidney allograft recipient is currently about 4% [1]. Most of RCC are found in the recipient’s native kidneys and de novo RCC in renal allograft is a very rare event [3,4,5,6,7] Most of these tumors are papillary or clear cell carcinomas. We report the first case BKV-associated collecting duct carcinoma (CDC) of the renal allograft in an adult kidney-pancreas allograft recipient. F-18-fluoro2-deoxyglucose (FDG) positron emission tomography in combination with computed tomography (PET-ct) highlighted a peripheral hypermetabolism of the renal tumor, without evidence of any extrarenal tumor At this time, BKV viremia titers remained unchanged. Non-tumor allograft parenchyma showed no evidence of BKV nephropathy and was totally negative for SV40 immunostaining (Figure 3). With a 9-months follow-up, the evolution is free from clinical and radiological progression

DISCUSSION
MATERIALS AND METHODS
Findings
CONFLICTS OF INTEREST
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call